Lista de obras - Philip R Quinlan - Dominio Público Uruguay

A Data-Centric Strategy for Modern Biobanking

artículo científico publicado en 2015

A Hybrid Architecture (CO-CONNECT) to Facilitate Rapid Discovery and Access to Data Across the United Kingdom in Response to the COVID-19 Pandemic: Development Study

artículo científico publicado en 2022

A Pin1/mutant p53 axis promotes aggressiveness in breast cancer

artículo científico publicado en 2011

A comparative biomarker study of 514 matched cases of male and female breast cancer reveals gender-specific biological differences

artículo científico publicado en 2011

A data standard for sourcing fit-for-purpose biological samples in an integrated virtual network of biobanks

artículo científico publicado en 2014

An integrated informatics platform to facilitate transforming tissue into knowledge.

artículo científico publicado en 2010

CYP2D6 genotype affects outcome in postmenopausal breast cancer patients treated with tamoxifen monotherapy.

artículo científico publicado en 2010

Comprehensive CYP2D6 genotype and adherence affect outcome in breast cancer patients treated with tamoxifen monotherapy

artículo científico

Endoglin expression in breast tumor cells suppresses invasion and metastasis and correlates with improved clinical outcome.

artículo científico publicado en 2010

Expression profiling of nuclear receptors in breast cancer identifies TLX as a mediator of growth and invasion in triple-negative breast cancer

artículo científico publicado en 2015

FGFR2 protein expression in breast cancer: nuclear localisation and correlation with patient genotype.

artículo científico publicado en 2011

High CCND1 amplification identifies a group of poor prognosis women with estrogen receptor positive breast cancer

artículo científico publicado en 2010

High frequency of complex TP53 mutations in CNS metastases from breast cancer.

artículo científico publicado en 2011

Histological evaluation of AMPK signalling in primary breast cancer

artículo científico publicado en 2009

Immunohistochemical detection of Polo-like kinase-1 (PLK1) in primary breast cancer is associated with TP53 mutation and poor clinical outcom

artículo científico publicado en 2012

Increased mortality in HER2 positive, oestrogen receptor positive invasive breast cancer: a population-based study

artículo científico publicado en 2010

Lessons learned from the COVID-19 pandemic about sample access for research in the UK

scientific article published in 2022

MAGE-A Cancer/Testis Antigens Inhibit MDM2 Ubiquitylation Function and Promote Increased Levels of MDM4

artículo científico publicado en 2015

Multiparameter DNA content analysis identifies distinct groups in primary breast cancer.

artículo científico publicado en 2013

Mutant p53 accumulation in human breast cancer is not an intrinsic property or dependent on structural or functional disruption but is regulated by exogenous stress and receptor status.

artículo científico publicado en 2014

NT5E CpG island methylation is a favourable breast cancer biomarker ⬇️

artículo científico publicado el 31 de mayo de 2012

Pan-cancer analysis reveals TAp63-regulated oncogenic lncRNAs that promote cancer progression through AKT activation

scientific article published on 14 October 2020

Progesterone receptor expression is an independent prognostic variable in early breast cancer: a population-based study

scientific article published on 03 December 2013

Prospective comparison of switches in biomarker status between primary and recurrent breast cancer: the Breast Recurrence In Tissues Study (BRITS).

artículo científico publicado en 2010

TP53 drives invasion through expression of its Δ133p53β variant

artículo científico publicado en 2016

The Informatics Challenges Facing Biobanks: A Perspective from a United Kingdom Biobanking Network.

artículo científico publicado en 2015

The RNA helicase p68 modulates expression and function of the Δ133 isoform(s) of p53, and is inversely associated with Δ133p53 expression in breast cancer

artículo científico publicado en 2010

The RNA helicase/transcriptional co-regulator, p68 (DDX5), stimulates expression of oncogenic protein kinase, Polo-like kinase-1 (PLK1), and is associated with elevated PLK1 levels in human breast cancers

artículo científico publicado en 2014

Tissue confirmation of disease recurrence in breast cancer patients: pooled analysis of multi-centre, multi-disciplinary prospective studies.

artículo científico publicado en 2011

Transforming growth factor-beta co-receptor endoglin suppresses breast cancer invasion and metastasis.

artículo científico publicado en 2010

p53 mutant breast cancer patients expressing p53γ have as good a prognosis as wild-type p53 breast cancer patients.

artículo científico publicado en 2011

p53 mutation, deprivation and poor prognosis in primary breast cancer

artículo científico publicado en 2010

Lista de obras de Philip R Quinlan

A Data-Centric Strategy for Modern Biobanking

A Hybrid Architecture (CO-CONNECT) to Facilitate Rapid Discovery and Access to Data Across the United Kingdom in Response to the COVID-19 Pandemic: Development Study

A Pin1/mutant p53 axis promotes aggressiveness in breast cancer

A comparative biomarker study of 514 matched cases of male and female breast cancer reveals gender-specific biological differences

A data standard for sourcing fit-for-purpose biological samples in an integrated virtual network of biobanks

An integrated informatics platform to facilitate transforming tissue into knowledge.

CYP2D6 genotype affects outcome in postmenopausal breast cancer patients treated with tamoxifen monotherapy.

Comprehensive CYP2D6 genotype and adherence affect outcome in breast cancer patients treated with tamoxifen monotherapy

Endoglin expression in breast tumor cells suppresses invasion and metastasis and correlates with improved clinical outcome.

Expression profiling of nuclear receptors in breast cancer identifies TLX as a mediator of growth and invasion in triple-negative breast cancer

FGFR2 protein expression in breast cancer: nuclear localisation and correlation with patient genotype.

High CCND1 amplification identifies a group of poor prognosis women with estrogen receptor positive breast cancer

High frequency of complex TP53 mutations in CNS metastases from breast cancer.

Histological evaluation of AMPK signalling in primary breast cancer

Immunohistochemical detection of Polo-like kinase-1 (PLK1) in primary breast cancer is associated with TP53 mutation and poor clinical outcom

Increased mortality in HER2 positive, oestrogen receptor positive invasive breast cancer: a population-based study

Lessons learned from the COVID-19 pandemic about sample access for research in the UK

MAGE-A Cancer/Testis Antigens Inhibit MDM2 Ubiquitylation Function and Promote Increased Levels of MDM4

Multiparameter DNA content analysis identifies distinct groups in primary breast cancer.

Mutant p53 accumulation in human breast cancer is not an intrinsic property or dependent on structural or functional disruption but is regulated by exogenous stress and receptor status.

NT5E CpG island methylation is a favourable breast cancer biomarker ⬇️

Pan-cancer analysis reveals TAp63-regulated oncogenic lncRNAs that promote cancer progression through AKT activation

Progesterone receptor expression is an independent prognostic variable in early breast cancer: a population-based study

Prospective comparison of switches in biomarker status between primary and recurrent breast cancer: the Breast Recurrence In Tissues Study (BRITS).

TP53 drives invasion through expression of its Δ133p53β variant

The Informatics Challenges Facing Biobanks: A Perspective from a United Kingdom Biobanking Network.

The RNA helicase p68 modulates expression and function of the Δ133 isoform(s) of p53, and is inversely associated with Δ133p53 expression in breast cancer

The RNA helicase/transcriptional co-regulator, p68 (DDX5), stimulates expression of oncogenic protein kinase, Polo-like kinase-1 (PLK1), and is associated with elevated PLK1 levels in human breast cancers

Tissue confirmation of disease recurrence in breast cancer patients: pooled analysis of multi-centre, multi-disciplinary prospective studies.

Transforming growth factor-beta co-receptor endoglin suppresses breast cancer invasion and metastasis.

p53 mutant breast cancer patients expressing p53γ have as good a prognosis as wild-type p53 breast cancer patients.

p53 mutation, deprivation and poor prognosis in primary breast cancer